For example, Theodoraki et al.39evaluated the potential of PD-L1+ exosomes from the plasma of Head and Neck Squamous Cell Carcinoma (HNSCC) patients as markers of disease activity and immunosuppressive status. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.